399
Views
31
CrossRef citations to date
0
Altmetric
Research Article

Selective Inhibition of Vascular Endothelial Growth Factor Receptor‐2 (VEGFR‐2) Identifies a Central Role for VEGFR‐2 in Human Aortic Endothelial Cell Responses to VEGF

, , , & , M.D., Ph.D.
Pages 239-254 | Published online: 10 Jul 2003

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ian M. Evans, Maiko Yamaji, Gary Britton, Caroline Pellet-Many, Claire Lockie, Ian C. Zachary & Paul Frankel. (2011) Neuropilin-1 Signaling through p130Cas Tyrosine Phosphorylation Is Essential for Growth Factor-Dependent Migration of Glioma and Endothelial Cells. Molecular and Cellular Biology 31:6, pages 1174-1185.
Read now

Articles from other publishers (30)

Sarath Babu Nukala, Jordan Jousma, Gege Yan, Zhenbo Han, Youjeong Kwon, Yoonje Cho, Chuyu Liu, Keith Gagnon, Sandra Pinho, Jalees Rehman, Ning-Yi Shao, Sang-Bing Ong, Won Hee Lee & Sang-Ging Ong. (2023) Modulation of lncRNA links endothelial glycocalyx to vascular dysfunction of tyrosine kinase inhibitor. Cardiovascular Research 119:10, pages 1997-2013.
Crossref
Mika Brown, Shirley Zhu, Lorne Taylor, Maryam Tabrizian & Nicole Y. K. Li-Jessen. (2023) Unraveling the Relevance of Tissue‐Specific Decellularized Extracellular Matrix Hydrogels for Vocal Fold Regenerative Biomaterials: A Comprehensive Proteomic and In Vitro Study. Advanced NanoBiomed Research 3:4.
Crossref
Yang Liu, Xingli Gao, Songwei Gao, Yu Song, Yongran Guo & Jing Cao. (2022) Placental Therapeutic Targets and Nanodelivery Systems. Molecular Pharmaceutics 19:11, pages 3730-3748.
Crossref
Si Won Oh, Won-Sik Shin & Seung-Taek Lee. (2022) Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function. Cancers 14:18, pages 4463.
Crossref
Juan Antonio Giménez-Bastida, María Ángeles Ávila-Gálvez, Miguel Carmena-Bargueño, Horacio Pérez-Sánchez, Juan Carlos Espín & Antonio González-Sarrías. (2022) Physiologically relevant curcuminoids inhibit angiogenesis via VEGFR2 in human aortic endothelial cells. Food and Chemical Toxicology 166, pages 113254.
Crossref
Rongrong Wu, Wangxing Hu, Huan Chen, Yingchao Wang, Qingju Li, Changchen Xiao, Lin Fan, Zhiwei Zhong, Xiaoying Chen, Kaiqi Lv, Shuhan Zhong, Yanna Shi, Jinghai Chen, Wei Zhu, Jianyi Zhang, Xinyang Hu & Jian'an Wang. (2021) A Novel Human Long Noncoding RNA SCDAL Promotes Angiogenesis through SNF5‐Mediated GDF6 Expression . Advanced Science 8:18, pages 2004629.
Crossref
Hikaru Nagano, Chisato Tomida, Naoko Yamagishi & Shigetada Teshima-Kondo. (2019) VEGFR-1 Regulates EGF-R to Promote Proliferation in Colon Cancer Cells. International Journal of Molecular Sciences 20:22, pages 5608.
Crossref
Mélanie Marie, Pauline Gondouin, Delphine Pagan, Coralie Barrau, Thierry Villette, José Sahel & Serge Picaud. (2019) Blue-violet light decreases VEGFa production in an in vitro model of AMD. PLOS ONE 14:10, pages e0223839.
Crossref
Tania Durré, Florent Morfoisse, Charlotte Erpicum, Marie Ebroin, Silvia Blacher, Melissa García-Caballero, Christophe Deroanne, Thomas Louis, Cédric Balsat, Maureen Van de Velde, Seppo Kaijalainen, Frédéric Kridelka, Lars Engelholm, Ingrid Struman, Kari Alitalo, Niels Behrendt, Jenny Paupert & Agnès Noel. (2018) uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis. Nature Communications 9:1.
Crossref
Carla M. Cannizzo, Aaron A. Adonopulos, Emma L. Solly, Anisyah Ridiandries, Laura Z. Vanags, Jocelyne Mulangala, Sui Ching G. Yuen, Tania Tsatralis, Rodney Henriquez, Stacy Robertson, Stephen J. Nicholls, Belinda A. Di Bartolo, Martin K. C. Ng, Yuen Ting Lam, Christina A. Bursill & Joanne T. M. Tan. (2018) VEGFR2 is activated by high‐density lipoproteins and plays a key role in the proangiogenic action of HDL in ischemia. The FASEB Journal 32:6, pages 2911-2922.
Crossref
Helena VazãoSusana RosaTânia BarataRicardo CostaPatrícia R. PitrezInês HonórioMargreet R. de VriesDimitri PapatsenkoRui BeneditoDaniel SarisAli KhademhosseiniPaul H. A. QuaxCarlos F. PereiraNadia MercaderHugo Fernandes & Lino Ferreira. (2017) High-throughput identification of small molecules that affect human embryonic vascular development. Proceedings of the National Academy of Sciences 114:15.
Crossref
Heidi A. Trau, Mats Br?nnstr?m, Thomas E. CurryJrJr & Diane M. Duffy. (2016) Prostaglandin E2 and vascular endothelial growth factor A mediate angiogenesis of human ovarian follicular endothelial cells. Human Reproduction, pages dev320.
Crossref
Angela Barrett, Caroline Pellet-Many, Ian C. Zachary, Ian M. Evans & Paul Frankel. (2013) p130Cas: A key signalling node in health and disease. Cellular Signalling 25:4, pages 766-777.
Crossref
Amira Othman, Saif Ahmad, Sylvia Megyerdi, Rene Mussell, Karishma Choksi, Krishna Rao Maddipati, Ahmed Elmarakby, Nasser Rizk & Mohamed Al-Shabrawey. (2013) 12/15-Lipoxygenase-Derived Lipid Metabolites Induce Retinal Endothelial Cell Barrier Dysfunction: Contribution of NADPH Oxidase. PLoS ONE 8:2, pages e57254.
Crossref
Roberto E Favoni, Antonio Daga, Paolo Malatesta & Tullio Florio. (2012) Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma. British Journal of Pharmacology 166:2, pages 532-553.
Crossref
Radhika Susarla, John C. Watkinson & Margaret C. Eggo. (2012) Regulation of human thyroid follicular cell function by inhibition of vascular endothelial growth factor receptor signalling. Molecular and Cellular Endocrinology 351:2, pages 199-207.
Crossref
Hanbing Zhong, Danyang Wang, Nan Wang, Yesenia Rios, Haigen Huang, Song Li, Xinrong Wu & Shuo Lin. (2011) Combinatory action of VEGFR2 and MAP kinase pathways maintains endothelial-cell integrity. Cell Research 21:7, pages 1080-1087.
Crossref
Tong T. Zhao, Diane Trinh, Christina L. Addison & Jim Dimitroulakos. (2010) Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors. PLoS ONE 5:9, pages e12563.
Crossref
Sébastien Toffoli, Edouard Delaive, Marc Dieu, Olivier Feron, Martine Raes & Carine Michiels. (2009) NDRG1 and CRK-I/II are regulators of endothelial cell migration under intermittent hypoxia. Angiogenesis 12:4, pages 339-354.
Crossref
Kuo-Hui Su, Jin-Yi Tsai, Yu Ru Kou, An-Na Chiang, Sheng-Huang Hsiao, Yuh-Lin Wu, Hsin-Han Hou, Ching-Chian Pan, Song-Kun Shyue & Tzong-Shyuan Lee. (2009) Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling. Cardiovascular Research 82:3, pages 468-475.
Crossref
Barbara Olszewska-Pazdrak, Travis W. Hein, Paulina Olszewska & Darrell H. Carney. (2009) Chronic hypoxia attenuates VEGF signaling and angiogenic responses by downregulation of KDR in human endothelial cells. American Journal of Physiology-Cell Physiology 296:5, pages C1162-C1170.
Crossref
Whitney A. Spannuth, Alpa M. Nick, Nicholas B. Jennings, Guillermo N. Armaiz-Pena, Lingegowda S. Mangala, Christopher G. Danes, Yvonne G. Lin, William M. Merritt, Premal H. Thaker, Aparna A. Kamat, Liz Y. Han, James R. Tonra, Robert L. Coleman, Lee M. Ellis & Anil K. Sood. (2009) Functional significance of VEGFR-2 on ovarian cancer cells. International Journal of Cancer 124:5, pages 1045-1053.
Crossref
Ifat Sher, Sirin A. Adham, James Petrik & Brenda L. Coomber. (2008) Autocrine VEGF‐A/KDR loop protects epithelial ovarian carcinoma cells from anoikis. International Journal of Cancer 124:3, pages 553-561.
Crossref
Malgorzata M. Ptaszynska, Michael L. Pendrak, Russell W. Bandle, Mary L. Stracke & David D. Roberts. (2008) Positive Feedback between Vascular Endothelial Growth Factor-A and Autotaxin in Ovarian Cancer Cells. Molecular Cancer Research 6:3, pages 352-363.
Crossref
Stephen G. Ball, C. Adrian Shuttleworth & Cay M. Kielty. (2007) Vascular endothelial growth factor can signal through platelet-derived growth factor receptors. The Journal of Cell Biology 177:3, pages 489-500.
Crossref
H S Qian, P Liu, L-Y Huw, A Orme, M Halks-Miller, S M Hill, F Jin, P Kretschmer, E Blasko, L Cashion, P Szymanski, R Vergona, R Harkins, J Yu, W C Sessa, W P Dole, G M Rubanyi & K Kauser. (2006) Effective treatment of vascular endothelial growth factor refractory hindlimb ischemia by a mutant endothelial nitric oxide synthase gene. Gene Therapy 13:18, pages 1342-1350.
Crossref
Hu Sheng Qian, Micheline Monterio de Resende, Christian Beausejour, Ling-Yuh Huw, Perry Liu, Gabor M. Rubanyi & Katalin Kauser. (2006) Age-Dependent Acceleration of Ischemic Injury in Endothelial Nitric Oxide Synthase-Deficient Mice: Potential Role of Impaired VEGF Receptor 2 Expression. Journal of Cardiovascular Pharmacology 47:4, pages 587-593.
Crossref
Jean-Pierre Dollé, Amir Rezvan, Fred D. Allen, Philip Lazarovici & Peter I. Lelkes. (2005) Nerve Growth Factor-Induced Migration of Endothelial Cells. Journal of Pharmacology and Experimental Therapeutics 315:3, pages 1220-1227.
Crossref
Timothy S. Collins & Herbert I. Hurwitz. (2005) Targeting vascular endothelial growth factor and angiogenesis for the treatment of colorectal cancer. Seminars in Oncology 32:1, pages 61-68.
Crossref
Yun-He Jia. (2004) Effects of endostatin on expression of vascular endothelial growth factor and its receptors and neovascularization in colonic carcinoma implanted in nude mice. World Journal of Gastroenterology 10:22, pages 3361.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.